PHARMACOKINETICS OF KETOROLAC AND P-HYDROXYKETOROLAC FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATION OF KETOROLAC TROMETHAMINE

被引：37
作者：
JUNG, D
MROSZCZAK, EJ
WU, A
LING, TL
SEVELIUS, H
BYNUM, L
机构：
来源：
PHARMACEUTICAL RESEARCH | 1989年 / 6卷 / 01期
关键词：
D O I：
10.1023/A:1015803803650
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：62 / 65
页数：4
相关论文
共 15 条
[1]  
BLOOMFIELD SS, 1984, CLIN PHARMACOL THER, V35, P228
[2]  
BROWN CR, 1988, CLIN PHARMACOL THER, V43, P142
[3]  
HILLIER K, 1981, Drugs of the Future, V6, P669
[4]  
JUNG DW, UNPUB
[5]  
Miller R., 1981, SIMULTANEOUS STATIST
[6]  
MROSZCZAK EJ, 1985, CLIN PHARMACOL THER, V37, P215
[7]  
MROSZCZAK EJ, 1987, DRUG METAB DISPOS, V15, P618
[8]  
MUCHOWSKI JM, 1982, J MED CHEM, V28, P1037
[9]   THE ANALGESIC AND ANTI-INFLAMMATORY PROFILE OF (+/-)-5-BENZOYL-1,2-DIHYDRO-3H-PYRROLO[1,2A]PYRROLE-1-CARBOXYLIC ACID (RS-37619) [J].
ROOKS, WH ;
TOMOLONIS, AJ ;
MALONEY, PJ ;
WALLACH, MB ;
SCHULER, ME .
AGENTS AND ACTIONS, 1982, 12 (5-6) :684-690
[10]  
ROOKS WH, 1985, DRUG EXP CLIN RES, V11, P479
12